dihexa solubility dmso mg/ml 10mg DMSO Solubility Assessment for Fragment-Based
Description
298 H1155H1165

Note, the similar beneficial results of BPC 157 therapy obtained after different application routes are consistent with the high applicability of the agent, whatever route of the application [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40] overwhelms limited applicability and activity to prophylactic application only of standard cytoprotective agents [41,42,43,44,45,46,47,48,49]

Promising preclinical results is not the same as proven to work in humans. If youre using these compounds, you should understand that youre operating ahead of the clinical evidence

How does a substance or method get included on the WADA Prohibited List

& Smith, D
